DVN three-lens brief
Evidence-based stock research on DVN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 21.3pp over 30 days. · Debt-to-equity of 56.4 — balance-sheet-heavy.
- Underperforming SPY by 21.3pp over 30 days.
- Analyst mean target $59.42 — 28% above current (24 analysts).
- Debt-to-equity of 56.4 — balance-sheet-heavy.
DVN closed at $46.31 (-0.98%) as of 2026-05-13. Market cap: $53.39B. P/E (trailing) 12.9. Positives: analyst mean target $59.42 — 28% above current (24 analysts).. Concerns: underperforming SPY by 21.3pp over 30 days.; debt-to-equity of 56.4 — balance-sheet-heavy.. Last quarter: Revenue $3.81B, net income $120.00M, free cash flow $1.60B.
Why three lenses on DVN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DVNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DVN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DVN brief"></iframe>